DEA issues dire warning on fentanyl mixed with flesh-eating ‘Tranq’ zombie drug seized in 48 of 50 states

buy oxycodone online overnight delivery

buy oxycodone online overnight delivery.By Danielle Wallace | Fox News

close

https://static.foxnews.com/static/orion/html/video/iframe/vod.html?v=20230427212828#uid=fnc-embed-1&url=www.foxnews.com%2Fus%2Fdea-issues-dire-warning-fentanyl-mixed-flesh-eating-tranq-zombie-drug-seized-48-50-states

New ‘zombie’ drug laced with fentanyl can ‘eat flesh’: ‘It’s absolutely horrible’

The U.S. Drug Enforcement Administration (DEA) issued a dire warning regarding fentanyl mix with a flesh-eating “Tranq” zombie drug that has been seize in 48 out of 50 states so far. 

In a new public safety alert, the DEA said it was warning the American public of a sharp increase in the trafficking of fentanyl mixed with xylazine. Xylazine, also known as “Tranq,” is a powerful sedative that the U.S. Food and Drug Administration (FDA) has approved for veterinary use.    

“Xylazine is making the deadliest drug threat our country has ever faced, fentanyl, even deadlier,” DEA administrator Anne Milgram said. “DEA has seized xylazine and fentanyl mixtures in 48 of 50 States. The DEA Laboratory System is reporting that in 2022 approximately 23% of fentanyl powder and 7% of fentanyl pills seized by the DEA contained xylazine.”

The alert says xylazine and fentanyl drug mixtures place users at a higher risk of suffering fatal drug poisoning. Because xylazine is not an opioid, naloxone (Narcan) does not reverse its effects. 

ANIMAL TRANQUILIZED MIXED WITH FENTANYL ROTS SKIN, TURNS HUMAN INTO ‘ZOMBIES’: ‘THE WALKING DEAD’

DEA administrator and US attorney general

DEA administrator Anne Milgram, right, warned of a sharp increase in the trafficking of fentanyl mixed with xylazine. (Alex Wong/Getty Images)

“Still, experts always recommend administering naloxone if someone might be suffering a drug poisoning,” the alert said. “People who inject drug mixtures containing xylazine also can develop severe wounds, including necrosis—the rotting of human tissue—that may lead to amputation.”

According to the U.S. Centers for Disease Control and Prevention, 107,735 Americans died between August 2021 and August 2022 from drug poisonings, with 66% of those deaths involving synthetic opioids like fentanyl. 

Philadelphia drug use

“Tranq” was found in over 90% of Philadelphia’s drug supply. (Lokman Vural Elibol/Anadolu Agency via Getty Images)

“The Sinaloa Cartel and Jalisco

 Cartel in Mexico, using chemicals largely source from China, are primarily responsible for the vast majority of the fentanyl that is being trafficked in communities across the United States,” the DEA alert add. 

FAIRFAX COUNTY SCHOOLS ACCUSED OF COVERING UP ‘GANG RAPE’ AS MS-13 TRAFFICKERS PLAGUED DISTRICT: LAWSUIT 

The FDA recently communicated to health care providers about the risks to patients exposed to xylazine in illicit drugs. That message says xylazine “is not safe for use in humans and may result in serious and life-threatening side effects that appear to be similar to those commonly associated with opioid use, making it difficult to distinguish opioid overdoses from xylazine exposure.” 

DEA badges

The DEA warned animal tranquilizer mixed with fentanyl rots human tissue. (AGNES BUN/AFP via Getty Images)

Because routine toxicology screens do not detect xylazine,

health care professionals are urge to check patients for other signs or symptoms of xylazine exposure including “severe, necrotic skin ulcerations.” 

CLICK HERE TO GET THE FOX NEWS APP

In February, a Philadelphia business owner and prior drug addict detail to Fox News Digital how bags of “Tranq dope” were being sold for as little as $4 a pop in his community, describing what it was like walking past groups of maybe three or four people strung out on the streets and smelling of “rotting flesh” from open sores. 

Xylazine was found in over 90% of drug samples test in Philadelphia in 2021, according to Substance Use Philly. 

shop

Leave a Reply

Your email address will not be published. Required fields are marked *